Does isolated neutropenia with normal hemoglobin and platelets indicate lineage-selective suppression?

In hematopoietic pathology, the distinction between lineage-specific suppression and global bone marrow failure is primarily driven by the breadth of the cytopenia and the underlying cellular environment. The presentation of isolated neutropenia (absolute neutrophil count <1.5 × 10⁹/L) alongside stable hemoglobin and platelet levels is a classic diagnostic marker for processes that target the myeloid compartment specifically rather than the entire stem cell pool.

Clinical and Pathophysiological Mechanisms

Evidence indicates that isolated neutropenia with preserved other cell lines characterizes specific inflammatory or immune-mediated disorders rather than the broad collapse of hematopoiesis.

• Inflammatory Reprogramming: In conditions like chronic idiopathic neutropenia (CIN), the bone marrow microenvironment is altered by proinflammatory cytokines, specifically TNF-α, IFN-γ, and IL-1β. These mediators, along with proapoptotic factors like Fas-ligand, selectively impair neutrophil maturation and survival while erythropoiesis (red cell production) and thrombopoiesis (platelet production) remain intact.
• Comparison to Global Failure: Global bone marrow failure, such as aplastic anemia, is defined by pancytopenia—a quantitative reduction across all hematopoietic stem cell outputs. This is often driven by cytotoxic T-cell destruction of stem and progenitor cells, leading to a severely hypocellular marrow (often <30% cellularity). In contrast, lineage-selective suppression usually maintains a normocellular or hypercellular marrow, even if it demonstrates "maturation arrest" in the neutrophil line.

Selective Suppression Pathways

The preservation of other lineages suggests that the insult is occurring at the progenitor level or through niche-mediated signaling.

• Niche Signaling: Specific stromal cell signaling can direct stem cells toward certain lineages while others remain unaffected. Research has shown that specific toxins or immune responses can deplete lymphoid or myeloid progenitors while sparing the multipotent hematopoietic stem cells.
• Alternative Diagnoses: While early myelodysplastic syndromes (MDS) can occasionally present with a single cytopenia, the persistent preservation of multiple other cell lines typically shifts the clinical focus toward autoimmune neutropenia (AIN), drug-induced effects, or specific inflammatory syndromes rather than a generalized marrow failure.

Bottom line

A pattern of isolated neutropenia with normal red cell and platelet indices is highly suggestive of lineage-selective suppression. This state is typically driven by cytokine-mediated pathways or immune-mediated destruction targeting specific myeloid precursors, contrasting with the pan-lineage collapse and marrow hypocellularity characteristic of global bone marrow failure.